Back to results
US 2011/0086875 A1Published application
Powdered Medicament for Nasal Delivery of Ascorbic Acid for Reducing Apomorphine Induced Toxicity to Ciliated Tissue
AssigneeBritannia Pharmaceuticals Limited
InventorsPeter Alan Lambert, Franciscus Merkus
Life of this patent
Estimating the term…
Abstract
Use of ascorbic acid in the manufacture of a powdered medicament for nasal delivery, said medicament comprising an active agent such as apomorphine that exhibits toxicity to ciliated tissue, for ameliorating said toxicity.
Claims10
1-9. (canceled)
A method for ameliorating the toxicity to ciliated tissue of a nasally-administered powdered medicament, the method comprising administering the medicament with ascorbic acid, wherein the medicament comprises an active agent that is toxic to ciliated tissue.
Dependencies are inferred from the claim text.